» Articles » PMID: 37614378

Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2023 Aug 24
PMID 37614378
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We established a nomogram for ketosis-prone type 2 diabetes mellitus (KP-T2DM) in the Chinese adult population in order to identify high-risk groups early and intervene in the disease progression in a timely manner.

Methods: We reviewed the medical records of 924 adults with newly diagnosed T2DM from January 2018 to June 2021. All patients were randomly divided into the training and validation sets at a ratio of 7:3. The least absolute shrinkage and selection operator regression analysis method was used to screen the predictors of the training set, and the multivariable logistic regression analysis was used to establish the nomogram prediction model. We verified the prediction model using the receiver operating characteristic (ROC) curve, judged the model's goodness-of-fit using the Hosmer-Lemeshow goodness-of-fit test, and predicted the risk of ketosis using the decision curve analysis.

Results: A total of 21 variables were analyzed, and four predictors-hemoglobin A1C, 2-hour postprandial blood glucose, 2-hour postprandial C-peptide, and age-were established. The area under the ROC curve for the training and validation sets were 0.8172 and 0.8084, respectively. The Hosmer-Lemeshow test showed that the prediction model and validation set have a high degree of fit. The decision curve analysis curve showed that the nomogram had better clinical applicability when the threshold probability of the patients was 0.03-0.79.

Conclusion: The nomogram based on hemoglobin A1C, 2-hour postprandial blood glucose, 2-hour postprandial C-peptide, and age has good performance and can serve as a favorable tool for clinicians to predict KP-T2DM.

Citing Articles

Development and validation of a nomogram for screening patients with type 2 diabetic ketoacidosis.

Li H, Su B, Li G BMC Endocr Disord. 2024; 24(1):148.

PMID: 39135031 PMC: 11318303. DOI: 10.1186/s12902-024-01677-3.


High Atherogenic Risk in Ketosis-Prone Type 2 Diabetic Individuals with Ketosis Episodes: A Cross-Sectional Study.

He X, Luo Y, Hao J, Hu R, Yang X, Ren L Diabetes Metab Syndr Obes. 2023; 16:3085-3094.

PMID: 37818406 PMC: 10561756. DOI: 10.2147/DMSO.S421203.

References
1.
Al Hayek A, Robert A, Al-Shaikh R, Alhojele M, Aloufi S, Sabri D . Factors associated with the presence of diabetic ketoacidosis: A retrospective analysis of patients with type 1 diabetes in Saudi Arabia. Diabetes Metab Syndr. 2021; 14(6):2117-2122. DOI: 10.1016/j.dsx.2020.11.002. View

2.
Waddankeri S, Swaraj Waddankeri M, Gurushantappa Mangshetty B . Clinical and Biochemical Characteristics and Treatment Outcomes of Ketosis-Prone Diabetes: The Remission Prone Diabetes. Int J Endocrinol Metab. 2021; 19(2):e106799. PMC: 8198612. DOI: 10.5812/ijem.106799. View

3.
Du S, Zhang H, Wu H, Ye S, Li W, Su Q . Prevalence and Gender Differences of Metabolic Syndrome in Young Ketosis-Prone Type 2 Diabetic Individuals: A Retrospective Study. Diabetes Metab Syndr Obes. 2020; 13:2719-2727. PMC: 7413718. DOI: 10.2147/DMSO.S252492. View

4.
Xie X, Hu Y, Cheng C, Feng T, He K, Mao X . Should diabetic ketosis without acidosis be included in ketosis-prone type 2 diabetes mellitus?. Diabetes Metab Res Rev. 2013; 30(1):54-9. DOI: 10.1002/dmrr.2448. View

5.
Darenskaya M, Kolesnikova L, Kolesnikov S . Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction. Bull Exp Biol Med. 2021; 171(2):179-189. PMC: 8233182. DOI: 10.1007/s10517-021-05191-7. View